Cited by 485Cardiac Imaging and DiagnosticsCardiovascular Health and Disease PreventionHealth Promotion and Cardiovascular Prevention

Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

Open access
Blaha, Michael J., Cainzos-Achirica, Miguel, Greenland, Philip, McEvoy, John W., Blankstein, Ron, Budoff, Matthew J., Dardari, Zeina, Sibley, Christopher T. +5 more·2016·Circulation

Abstract

Background—: Limited attention has been paid to negative cardiovascular disease (CVD) risk markers despite their potential to improve medical decision making. We compared 13 negative risk markers using diagnostic likelihood ratios (DLRs), which model the change in risk for an individual after the result of an additional test. Methods and Results—: We examined 6814 participants from the Multi-Ethnic Study of Atherosclerosis. Coronary artery calcium score of 0, carotid intima-media thickness <25th percentile, absence of carotid plaque, brachial flow-mediated dilation >5% change, ankle-brachial index >0.9 and <1.3, high-sensitivity C-reactive protein <2 mg/L, homocysteine <10 µmol/L, N-terminal pro-brain natriuretic peptide <100 pg/mL, no microalbuminuria, no family history of coronary heart disease (any/premature), absence of metabolic syndrome, and healthy lifestyle were compared for all and hard coronary heart disease and all CVD events over the 10-year follow-up. Models were adjusted for traditional CVD risk factors. Among all negative risk markers, coronary artery calcium score of 0 was the strongest, with an adjusted mean DLR of 0.41 (SD, 0.12) for all coronary heart disease and 0.54 (SD, 0.12) for CVD, followed by carotid intima-media thickness <25th percentile (DLR, 0.65 [SD, 0.04] and 0.75 [SD, 0.04], respectively). High-sensitivity C-reactive protein <2 mg/L and normal ankle-brachial index had DLRs >0.80. Among clinical features, absence of any family history of coronary heart disease was the strongest (DLRs, 0.76 [SD, 0.07] and 0.81 [SD, 0.06], respectively). Net reclassification improvement analyses yielded similar findings, with coronary artery calcium score of 0 resulting in the largest, most accurate downward risk reclassification. Conclusions—: Negative results of atherosclerosis-imaging tests, particularly coronary artery calcium score of 0, resulted in the greatest downward shift in estimated CVD risk. These results may help guide discussions on the identification of individuals less likely to receive net benefit from lifelong preventive pharmacotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.115.018524

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 32

  1. [1]27th Bethesda Conference Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events. September 14–15, 1995 J Am Coll Cardiol 1996 27 957 1047 8609361
  2. [3]Kildemoes HW Andersen M Støvring H The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: a pharmacoepidemiological projection approach Pharmacoepidemiol Drug Saf 2010 19 1276 1286 20954165
  3. [4]Karmali KN Goff DC Jr Ning H Lloyd-Jones DM A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease J Am Coll Cardiol 2014 64 959 968 25190228
  4. [5]Pencina MJ Navar-Boggan AM D’Agostino RB Sr Williams K Neely B Sniderman AD Peterson ED Application of new cholesterol guidelines to a population-based sample N Engl J Med 2014 370 1422 1431 24645848
  5. [6]Stone NJ Robinson JG Lichtenstein AH Bairey Merz CN Blum CB Eckel RH Goldberg AC Gordon D Levy D Lloyd-Jones DM McBride P Schwartz JS Shero ST Smith SC Jr Watson K Wilson PW ACC/AHA Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults J Am Coll Cardiol 2014 63 2889 2934 24239923
  6. [7]Ridker PM Cook NR Statins: new American guidelines for prevention of cardiovascular disease Lancet 2013 382 1762 1765 24268611
  7. [8]Hecht HS A zero coronary artery calcium score: priceless J Am Coll Cardiol 2010 55 1118 1120 20223366
  8. [9]Sarwar A Shaw LJ Shapiro MD Blankstein R Hoffmann U Cury RC Abbara S Brady TJ Budoff MJ Blumenthal RS Nasir K Diagnostic and prognostic value of absence of coronary artery calcification JACC Cardiovasc Imaging 2009 2 675 688 19520336
  9. [10]Janssens AC Deng Y Borsboom GJ Eijkemans MJ Habbema JD Steyerberg EW A new logistic regression approach for the evaluation of diagnostic test results Med Decis Making 2005 25 168 177 15800301
  10. [11]Gu W Pepe MS Estimating the capacity for improvement in risk prediction with a marker Biostatistics 2009 10 172 186 18714084 PMC2639345
  11. [12]Bild DE Bluemke DA Burke GL Detrano R Diez Roux AV Folsom AR Greenland P Jacob DR Jr Kronmal R Liu K Nelson JC O’Leary D Saad MF Shea S Szklo M Tracy RP Multi-ethnic study of atherosclerosis: objectives and design Am J Epidemiol 2002 156 871 881 12397006
  12. [13]Grundy SM Brewer HB Jr Cleeman JI Smith SC Jr Lenfant C American Heart Association; National Heart, Lung, Blood Institute Definition of metabolic syndrome Circulation 2004 109 433 438 14744958
  13. [14]Bertoni AG Whitt-Glover MC Chung H Le KY Barr RG Mahesh M Jenny NS Burke GL Jacobs DR The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis Am J Epidemiol 2009 169 444 454 19075250 PMC2726643
  14. [16]Sharma K Blaha MJ Blumenthal RS Musunuru K Clinical and research applications of carotid intima-media thickness Am J Cardiol 2009 103 1316 1320 19406278 PMC2691892
  15. [17]Bots ML Westerink J Rabelink TJ de Koning EJ Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur Heart J 2005 26 363 368 15618057
  16. [18]Tison GH Ndumele CE Gerstenblith G Allison MA Polak JF Szklo M Usefulness of baseline obesity to predict development of a high ankle brachial index (from the Multi-Ethnic Study of Atherosclerosis) Am J Cardiol 2011 107 1386 1391 21377643 PMC3079000
  17. [20]Veeranna V Zalawadiya SK Niraj A Pradhan J Ference B Burack RC Jacob S Afonso L Homocysteine and reclassification of cardiovascular disease risk J Am Coll Cardiol 2011 58 1025 1033 21867837
  18. [21]Sanchez OA Duprez DA Daniels LB Maisel AS Otvos JD Peralta CA Lima JA Bahrami H Jacobs DR Jr The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis Metabolism 2015 64 857 861 25931335 PMC4782748
  19. [22]Toto RD Microalbuminuria: definition, detection, and clinical significance J Clin Hypertens (Greenwich) 2004 6 11 Suppl 3 2 7 15538104 PMC8109505
  20. [23]Ahmed HM Blaha MJ Nasir K Jones SR Rivera JJ Agatston A Blankstein R Wong ND Lakoski S Budoff MJ Burke GL Sibley CT Ouyang P Blumenthal RS Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA Am J Epidemiol 2013 178 12 21 23733562 PMC3698994
  21. [24]Cook NR Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction Circulation 2007 115 928 935 17309939
  22. [25]Fontana M Asaria P Moraldo M Finegold J Hassanally K Manisty CH Francis DP Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility Circulation 2014 129 2539 2546 24744274 PMC4751622
  23. [26]Blaha MJ Silverman MG Budoff MJ Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Circ Cardiovasc Imaging 2014 7 398 408 24642922
  24. [27]Detrano R Guerci AD Carr JJ Bild DE Burke G Folsom AR Liu K Shea S Szklo M Bluemke DA O’Leary DH Tracy R Watson K Wong ND Kronmal RA Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 2008 358 1336 1345 18367736
  25. [29]Peters SAE den Ruijter HM Bots ML Moons KG Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review Heart 2012 98 177 184 22095617
  26. [30]Tota-Maharaj R Blaha MJ McEvoy JW Blumenthal RS Muse ED Budoff MJ Shaw LJ Berman DS Rana JS Rumberger J Callister T Rivera J Agatston A Nasir K Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults >75 years old Eur Heart J 2012 33 2955 2962 22843447
  27. [31]Silverman MG Blaha MJ Krumholz HM Budoff MJ Blankstein R Sibley CT Agatston A Blumenthal RS Nasir K Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis Eur Heart J 2014 35 2232 2241 24366919 PMC4150068
  28. [32]Gardin JM Bartz TM Polak JF O’Leary DH Wong ND What do carotid intima-media thickness and plaque add to the prediction of stroke and cardiovascular disease risk in older adults? The cardiovascular health study J Am Soc Echocardiogr 2014 27 998 1005 25172401 PMC4158921
  29. [33]Yousuf O Mohanty BD Martin SS Joshi PH Blaha MJ Nasir K Blumenthal RS Budoff MJ High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 2013 62 397 408 23727085
  30. [34]Ciampi A Courteau J Niyonsenga T Xhignesse M Lussier-Cacan S Roy M Family history and the risk of coronary heart disease: comparing predictive models Eur J Epidemiol 2001 17 609 620 12086074
  31. [36]Simon A Chironi G Levenson J Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals Eur Heart J 2007 28 2967 2971 17967818
  32. [37]Pepe MS Feng Z Gu JW Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification, beyond’ by M.J. Pencina et al., Statistics in Medicine Stat Med 2008 27 173 181 17671958

Cited by

Sorted by citations

Authors
Blaha, M. J., Cainzos-Achirica, M., Greenland, P., McEvoy, J. W., Blankstein, R., Budoff, M. J., Dardari, Z., Sibley, C. T., Burke, G. L., Kronmal, R. A., Szklo, M., Blumenthal, R. S., & Nasir, K.
Affiliations
  • Northwestern University (US)
  • From Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins Medical Institutions, Baltimore, MD (M.J.B., M.C.-A., J.W.M., Z.D., R.S.B., K.N.); Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD (M.C.-A.); Departments of Medicine and Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL (P.G.); Brigham and Women’s Hospital, Boston, MA (R.B.); Los Angeles Biomedical Research Institute at Harbor-UCLA,...
Corresponding author
Blaha, Michael J.
Venue
Circulation
Published
2016-03
Volume
133
Issue
9
Pages
849-858
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2292719256
Cited by
485
References
5
Citations by year
2026: 41 · 2025: 45 · 2024: 36 · 2023: 47 · 2022: 61 · 2021: 57 · 2020: 51 · 2019: 49 · 2018: 38 · 2017: 42 · 2016: 18
FWCI
42.54
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health (n01hc95164-17-0-1, UL1TR001420, n01hc95165-34-0-1, n01hc95161-24-0-1, n01hc095169-003, n01hc95166-21-0-1, n01hc95162-31-0-1, n01hc95168-27-0-1, n01hc95160-18-0-1, n01hc095167-000, UL1TR001079, n01hc95163-22-0-1, n01hc95159-40-0-1, UL1TR000040)
  • National Heart, Lung, and Blood Institute (N01 HC-95159, N01-HC-95160, N01-HC095169, N01 HC-95168, N01-HC-095165, N01 HC95167, (N01-HC-95163, N01 HC095163, N01 HC-95161, N01 HC95165, N01HC95164, N01-HC-095159, N01 HC095168, N01-HC-095162, N01-HC-095161, N01 HC095167, N01-HC-095160, N01 HC095166, N01 HC095164, N01‐HC‐95166, L30HL110027, N01 HC-95162, N01 HC95169)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
coronary heart disease risk, cardiovascular risk, diagnostic likelihood ratios, carotid intima-media thickness, ankle-brachial index, high-sensitivity C-reactive protein, family history of coronary heart disease, risk reclassification, Multi-Ethnic Study of Atherosclerosis
MeSH terms
Aged, C-Reactive Protein, Calcium, Cardiovascular Diseases, Coronary Vessels, Ethnicity, Female, Follow-Up Studies, Humans, Male, Middle Aged, Peptide Fragments, Prospective Studies, Risk Factors, Cohort Studies, Biomarkers, Natriuretic Peptide, Brain, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review